Assessment of chemical modifications of sites in the CDRs of recombinant antibodies: Susceptibility vs. functionality of critical quality attributes

MAbs. 2014 Mar-Apr;6(2):327-39. doi: 10.4161/mabs.27876. Epub 2014 Jan 17.

Abstract

Modifications like asparagine deamidation, aspartate isomerization, methionine oxidation, and lysine glycation are typical degradations for recombinant antibodies. For the identification and functional evaluation of antibody critical quality attributes (CQAs) derived from chemical modifications in the complementary-determining regions (CDRs) and the conserved regions, an approach employing specific stress conditions, elevated temperatures, pH, oxidizing agents, and forced glycation with glucose incubation, was applied. The application of the specific stress conditions combined with ion exchange chromatography, proteolytic peptide mapping, quantitative liquid chromatography mass spectrometry, and functional evaluation by surface plasmon resonance analysis was adequate to identify and functionally assess chemical modification sites in the CDRs of a recombinant IgG1. LC-Met-4, LC-Asn-30/31, LC-Asn-92, HC-Met-100c, and HC Lys-33 were identified as potential CQAs. However, none of the assessed degradation products led to a complete loss of functionality if only one light or heavy chain of the native antibody was affected.

Keywords: critical quality attributes; deamidation; developability; glycation; mass spectrometry; oxidation; protein degradation; quality by design; recombinant antibodies.

MeSH terms

  • Chromatography, Ion Exchange
  • Chromatography, Liquid
  • Complementarity Determining Regions / metabolism*
  • Glycation End Products, Advanced / metabolism*
  • Hot Temperature
  • Humans
  • Hydrogen-Ion Concentration
  • Immunoglobulin G / metabolism*
  • Mass Spectrometry
  • Oxidative Stress
  • Peptide Mapping / methods*
  • Protein Processing, Post-Translational
  • Proteolysis
  • Recombinant Proteins / metabolism*
  • Surface Plasmon Resonance

Substances

  • Complementarity Determining Regions
  • Glycation End Products, Advanced
  • Immunoglobulin G
  • Recombinant Proteins